In this study we revealed that CEPO, a carbamoyl derivative of EPO that does not affect erythropoiesis, attenuated myocardial pathological damage, at least in part through the activation of the PI3K/Akt signaling pathway, which regulates myocardial cell apoptosis in diabetes mellitus. The gene discussed is AKT1; the disease is diabetes mellitus.